A team led by Charité – Universitätsmedizin Berlin, German Rheumatology Research Center (DRFZ) and Max Delbrück Center have defined key cells behind severe kidney damage in lupus. The research, published in Nature,* could inform future antibody…
Eckert & Ziegler and Telix Pharmaceuticals Limited (Telix) today announced the signing of a significant multi-year agreement under which Eckert & Ziegler will serve as the European contract manufacturing organization (CMO) for Telix's ProstACT GLOBAL…
Researchers from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) and the German Center for Diabetes Research (DZD) have gained insights shedding light on the molecular adaptations occurring in skeletal muscle following bariatric…
The protective effects of fasting depend on an increase in the concentration of spermidine, according to an international study involving a team led by Professor Stephan Sigrist from Freie Universität Berlin.
2024 Network and business contacts that matter
Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) has received approval from the European Commission (EC) for its Ge-68/Ga-68 radionuclide generator GalliaPharm®. The generator was first launched in 2014 and is today approved in 17 European…
Gabriele Schiattarella researches the mechanisms of heart muscle weakness at the Max Delbrück Center and Deutsches Herzzentrum der Charité (DHZC). Now the International Society for Heart Research, a highly respected professional society, has named…
These awards recognize outstanding research and innovation in biotechnology and health, rewarding top projects in human and animal health. This year, the prize money is €40,000 for human health and €25,000 for animal health.Applications deadline:…
The Max Delbrück Center, Berlin, and the biotech company AlgenScribe from Nice have agreed to cooperate to further develop their gene-editing tools. The aim is to utilize synergies, accelerate research, and ultimately develop cell therapies for…
